The characteristics of disseminated tumor cells in pancreatic cancer: A black box needs to be explored

Pancreatology

Volumn 5, Issue 4-5, 2005, Pages 316-324

  Su, Dongming ^a   Yamaguchi, Koji ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Disseminated tumor cells; Micrometastasis; Pancreatic cancer

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKERATIN; CYTOKERATIN ANTIBODY; EOSIN; HEMATOXYLIN; K RAS PROTEIN; TUMOR ANTIGEN;

BLOOD DISEASE; BONE MARROW METASTASIS; CANCER DIAGNOSIS; CHROMOSOME ABERRATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PANCREAS CANCER; PANCREAS EXAMINATION; PERITONEAL CAVITY; PERITONEUM METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STANDARD; TUMOR CELL;

EID: 23844532654     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000086532     Document Type: Review

References (75)

1. Greenlee RT, Hill-Harmon M, Muzzay T, Thun M: Cancer statistics. CA Cancer J Clin 2001;51:15-36.
2. Brik D, Fortnagel G, Formentini A, Beger HG: Small carcinoma of the pancreas. Factors of prognostic relevance. J Hepatobiliary Pancreat Surg 1998;23:234-240.
3. Sobin LH, Wittekind CH: International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, ed 5. Wiley, 1997, pp 48-52.
4. Hermanek P, Sobin LH: UICC: TNM Classification of Malignant Tumors, ed 4, rev 2. Springer, 1992, pp 5-7.
5. Ridwelski K, Meyer F, Fahlke J, Kasper U, Roessner A, Lippert H: Value of cytokeratin and Ca 19-9 antigen in immunohistological detection of disseminated tumor cells in lymph nodes in pancreas carcinoma (in German). Chirurg 2001;72:920-926.
6. Robinson PJ: Imaging liver metastases: Current limitations and future prospects. Br J Radiol 2000;73:234-241.
7. Isozaki H, Okajima K, Fujii K: Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy. Hepatogastroenterology 1997;44:1133-1136.
8. Kanemitsu K, Hiraoka T, Tsuji T, Inoue K, Takamori H: Implication of micrometastasis of lymph nodes in patients with extended operation for pancreatic cancer. Pancreas 2003;26:315-321.
9. Braun S, Pantel K: Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat 1998;52:201-216.
10. Ghossein RA, Bhattacharya S: Molecular detection and characterization of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 2000;36:1681-1694.
11. Corson JM: Keratin protein immunohistochemistry in surgical pathology practice. Pathol Annu 1986;21:47-81.
12. Natsugoe S, Mueller J, Stein HJ, Feith M, Hofler J: Micrometastasis and tumor cell micro-involvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998;83:858-862.
13. Xu X, Robert SA, Pasha TL, Zhang J: Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 2000;124:1310-1312.
14. Brooks JS, LiVolsi VA, Pietra GG: Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol 1990;93:741-753.
15. Diel IJ, Cote RJ: Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer. Cancer Treat Rev 2000;26:53-65.
16. Hosch SB, Knoefel WT, Metz S: Early lymphatic tumor cell dissemination in pancreatic cancer: Frequency and prognostic significance. Pancreas 1997;15:154-159.
17. Vogel I, Kruger U, Marxsen J: Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: A new prognostic factor. Clin Cancer Res 1999;5:593-595.
18. Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R: Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. J Urol 2000;164:1834-1837.
19. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, Thorban S, Nekarda H, Siewert JR: Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002;49:150-158.
20. Bos JL: Ras oncogenes in human cancer: A review. Cancer Res 1989;49:4682-4689.
21. Lemoine NR, Jain S, Hughes C, Staddon S, Maillet B, Hall P, Klöppel G: Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992;102:230-236.
22. Queneau PE, Adessi GL, Thibault P: Early detection of pancreatic cancer in patients with chronic pancreatitis: Diagnostic utility of a K-ras point mutation in the pancreatic juice. Am J Gastroenterol 2001;96:700-704.
23. Löhr M, Maisonneuve P, Lowenfels AB: K-ras mutations and benign pancreatic disease. Int J Pancreatol 2000;27:93-103.
24. Löhr M, Muller P, Mora J, Brinkmann B, Ostwald C, Farre A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capella G, Liebe S: p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Gastrointest Endosc 2001;53:734-743.
25. Kaplan JC, Kahn A, Chelly J: Illegitimate transcription: Its use in the study of inherited disease. Hum Mutat 1992;1:357-360.
26. Ruud P, Fodstad O, Hovig E: Identification of a novel cytokeratin pseudogene that may interfere with reverse transcriptase polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999;80:119-125.
27. Krismann M, Todt B, Schroder J, Gareis D, Muller KM, Seeber S: Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995;13:2769-2775.
28. Berois N, Varangot M, Aizen B, Estrugo R, Zarantonelli L, Fernandez P: Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK-19, MUC1 and CEA using RT-PCR. Eur J Cancer 2000;36:717-723.
29. Kubota K, Nakanishi H, Hiki N, Shimizu N, Tsuji E, Yamaguchi H, Mafune K, Tange T, Tatematsu M, Kaminishi M: Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: A comparative study with immunohistochemistry. Int J Cancer 2003;105:136-143.
30. Vogel I, Kalthoff H, Henne-Bruns D, Kremer B: Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma. Pancreatology 2002;2:79-88.
31. Tamagawa E, Ueda M, Takahashi S, Sugano K, Uematsu S, Mukai M, Ogata Y, Kitajima M: Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: A new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997;3:2143-2149.
32. Ando N, Nakao A, Nomoto S, Takeda S, Kaneto T, Kurokawa T, Nonami T, Takagi H: Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic carcinoma. Pancreas 1997;15:374-378.
33. Demeure MJ, Doffek KM, Komorowski RA, Wilson SD: Adenocarcinoma of the pancreas. Detection of occult metastasis in regional lymph nodes by a polymerase chain reaction-based assay. Cancer 1998;83:1328-1334.
34. Demeure MJ, Doffek KM, Komorowski RA, Redlich PN, Wilson SD: Molecular metastasis in stage I pancreatic cancer: Improved survival with adjuvant chemoradiation. Surgery 1998;124:663-669.
35. Brown H, Ahrendt SA, Komorowski RA, Doffek KM, Wilson SD, Demeure MJ: Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer. J Surg Res 2000;95:141-146.
36. Japan Pancreas Society: Classification of Pancreatic Carcinoma, ed 1 (English). Kanahara & Co. Ltd., 1996.
37. Thorban S, Roder JD, Pantel K, Siewert JR: Epithelial tumor cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining. Eur J Cancer 1996;32:363-365.
38. Thorban S, Roder JD, Pantel K, Siewert JR: Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am J Surg 1996;172:297-298.
39. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M: Specific detection of carcinoembryonic antigen expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-729.
40. Juhl H, Kalthoff H, Kruger U, Schott A, Schreiber HW, Henne-Bruhns D, Kremer B: Immunzytologischer Nachweis disseminierter Tumorzellen in der Bauchhöhle und im Knochenmark von Pancreascarcinom-Patienten. Chirurg 1994;65:1111-1115.
41. Z'graggen, Centeno BA, Fernandez-del Castillo C, Jimenez RE, Werner J, Warshaw AL: Biological implications of tumor in blood and bone marrow of pancreatic cancer patients. Surgery 2001;129:537-546.
42. Tada M, Omata M, Kawai S, Ohto M, Saiki RK, Sninsky JJ: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic carcinoma. Cancer Res 1993;53:2472-2474.
43. Chausovsky G, Luchansky M, Fier A, Shapira J, Gottfried M, Novis B, Bogelman G, Zemer R, Zimlichman S, Klen A: Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of pancreas, colon, stomach and lung. Cancer 1999;86:2398-2405.
44. Miyazono F, Takao S, Natsugoe S, Uchikara K, KijamaF, Aridome K, Shinchi H, Aikou T: Molecular detection of circulating cancer cells in patients with biliary-pancreatic cancer. Am J Surg 1999;177:475-479.
45. Bilchik A, Miyashiro M, Kuo C, Fujiwara Y, Nakamori S, Monden M, Hoon DS: Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcription-polymerase chain reaction assay. Cancer 2000;88:1037-1044.
46. Martin JK Jr, Goellner JR: Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 1986;61:467-471.
47. Heeckt P, Safi F, Binder T, Buchler M: Freie intraperitoneale Tumorzellen beim Pankreas-carzinom-Bedeutung für den klinischen Verlauf und die Therapie. Chirurg 1992;63:563-567.
48. Warshaw AL: Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26-30.
49. Vogel I, Kruger U, Marxsen J, Soeth E, Kalthoff H, Henne-Bruns D, Kremer B, Juhl H: Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: A new prognostic factor. Clin Cancer Res 1999;5:593-599.
50. Inoue S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H: Detection of hepatic micrometastases in pancreatic carcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis. Jpn J Cancer Res 1995;86:626-630.
51. Nomoto S, Nakao A, Kasai Y, Inoue S, Takagi H: Peritoneal washing cytology combined with immunocytochemical staining and detecting mutant K-ras in pancreatic cancer: Comparison of the sensitivity and availability of various methods. Pancreas 1997;14:126-132.
52. Suwa H, Hosotani R, Okino T, Moden K, Arii S, Inoue K, Kore M, Ohshio G, Fukumoto M, Imamura M: Detection of extrahepatic nerve plexus invasion of pancreatic adenocarcinoma. Cytokeratin19 staining and K-ras mutation. Int J Pancreatol 1999;26:155-162.
53. Hermanek P, Hutter RV, Sobin LH, Wittekind C: Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
54. Tarin D: Cancer metastasis; in Peckham M, Pinedo H, Veronesi U (eds): Oxford Textbook of Oncology. Oxford, Oxford University Press, 1995, pp 118-132.
55. Tempia-Caliera AA, Horvath LZ, Zimmermann A, Tihanyi TT, Korc M, Friess H: Adhesion molecules in human pancreatic cancer. J Surg Oncol 2002;79:93-100.
56. Roep BO, Heidenthal E, de Vries RR, Kolb H, Martin S: Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 1994;343:1590-1594.
57. Varner J, Cheresh A: Integrin and cancer. Curr Opin Cell Biol 1996;8:724-730.
58. Kleiner DE, Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999;43(suppl):S42-S51.
59. Cantero D, Friess H, Deflorin J, Zimmermann A, Brundler MA, Riesle E: Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br J Cancer 1997;75:388-395.
60. Weiss L: Metastatic inefficiency. Adv Cancer Res1990, 54:159-211.
61. Abati A, Liotta LA: Looking forward in diagnostic pathology. The molecular superhighway. Cancer 1996;78:1-3.
62. Zhu ZY, Sanchez-Sweatman O, Huang XJ: Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res 2001;61:1707-1716.
63. Arvelo F, Poupon MF: Molecular and cell aspects of the cancer metastasis (in Spanish). Acta Cient Venez 2001;52:304-312.
64. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE: Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 2004;135:555-562.
65. Freeman JW, Busch RK, Gyorkey F, Gyorkey P, Ross BE, Busch H: Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase. Cancer Res 1988;48:1244-1251.
66. Rehders A, Hosch SB, Pantel K: Malignant phenotype of immunohistochemically detectable isolated tumor cells in lymph nodes of patients with esophageal cancer; in Encke A (ed): Deutsche Gesellschaft f. Chirurgie, Kongress-band 2000. Heidelberg, 2000, pp 121-122.
67. Luzz KJ, Macdonald LC, Schmidt EE: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153:865-873.
68. Paterson AHG: Bone metastases in breast cancer, prostate cancer and myeloma. Bone 1987; 8(suppl 1):17-22.
69. Pantel K, Cote RJ, Fodstad O: Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999;91:1113-1124.
70. Folkman J: What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
71. Ikeda N, Adachi M, Taki T: Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999;79:1553-1563.
72. Fujioka S, Yoshida K, Yanagisawa S: Angiogenesis in pancreatic carcinoma: Thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer 2001;92:1788-1797.
73. MacDonald IC, Groom AC, Chambers AF: Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. Bioassays 2002;24:885-893.
74. Vajkoczy P, Ullrich A, Menger MD: Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia 2000;2:53-61.
75. Bouvet M, Wang JW, Stephanie R: Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 2002;62:1534-1540.